Liqiong Cai

Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study

Kunyu Yang, Yuhan Sheng, Chaolin Huang et al. · The Lancet Oncology · 2020 · 600 citations · Full text

Medicine, Health Sciences, Oncology +16

Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study

Danying Liao, Fen Zhou, Lili Luo et al. · The Lancet Haematology · 2020 · 538 citations · Full text

Medicine, Hematology, Infectious Diseases +3

Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment

Liqiong Cai, Gaofei Xu, Changying Shi et al. · Biomaterials · 2014 · 148 citations · Full text

Pharmacy, Oncology, Pharmaceutics +16

Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair

Man Xiao, Jing Cai, Liqiong Cai et al. · Journal of Ovarian Research · 2017 · 70 citations · Full text

Medicine, Molecular Biology, Oncology +14

Boosting ferroptosis via abplatin(iv) for treatment of platinum-resistant recurrent ovarian cancer

Wenwen Wang, Jing Cai, Jiayi Wen et al. · Nano Today · 2022 · 58 citations

Medicine, Oncology, Pharmacology +12